These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32077782)

  • 1. The Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network: A New Model for Addressing Site-Level Factors Impacting Clinical Trial Enrollment.
    Roth M; Mittal N; Saha A; Freyer DR
    J Adolesc Young Adult Oncol; 2020 Aug; 9(4):522-527. PubMed ID: 32077782
    [No Abstract]   [Full Text] [Related]  

  • 2. Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials.
    Mittal N; Saha A; Avutu V; Monga V; Freyer DR; Roth M
    Sci Rep; 2022 Mar; 12(1):3875. PubMed ID: 35264642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial.
    Mittal N; Langevin AM; Kyono W; Dickens DS; Grimes A; Salsman JM; Pollock BH; Roth M
    J Adolesc Young Adult Oncol; 2022 Feb; 11(1):117-121. PubMed ID: 33983848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.
    Roth ME; O'Mara AM; Seibel NL; Dickens DS; Langevin AM; Pollock BH; Freyer DR
    J Oncol Pract; 2016 Apr; 12(4):e388-95. PubMed ID: 27026648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives.
    Siembida EJ; Loomans-Kropp HA; Tami-Maury I; Freyer DR; Sung L; Crosswell HE; Pollock BH; Roth ME
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34104866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of Teleconsent for Adolescent and Young Adult Cancer Clinical Trials, a Report from the Children's Oncology Group.
    Terao M; Mittal N; Roth M; Saha A; Super L; Reichek J
    J Adolesc Young Adult Oncol; 2024 Feb; 13(1):132-137. PubMed ID: 37540127
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.
    Thomas SM; Malvar J; Tran HH; Shows JT; Freyer DR
    Cancer; 2018 Oct; 124(20):4064-4071. PubMed ID: 30291804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities.
    Mittal N; Davidson J; Martinez MF; Sanchez R; Sane N; Giordano L; Choi DK; Kent P; Dighe D; Iqbal A; Kiely C; Breen K; Quigley JG; Catchatourian R; Gitelis S; Schmidt ML
    J Adolesc Young Adult Oncol; 2019 Jun; 8(3):227-235. PubMed ID: 30676208
    [No Abstract]   [Full Text] [Related]  

  • 9. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
    Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
    Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology.
    Roth ME; Grimes AC; Reed DR; Weiss AR; Mittal N; Parsons SK; Freyer DR;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30564. PubMed ID: 37439574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative study of barriers and facilitators to adolescents and young adults' participation in cancer clinical trials: Oncologist and patient perspectives.
    Abrahão R; Alvarez EM; Waters AR; Romero CC; Gosdin MM; Naz H; Pollock BH; Kirchhoff AC; Keegan THM
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29479. PubMed ID: 34913583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities.
    Winestone LE; Beauchemin MP; Bona K; Kahn J; Prasad P; Robles JM; Velez MC;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30592. PubMed ID: 37501542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention.
    Siembida EJ; Loomans-Kropp HA; Trivedi N; O'Mara A; Sung L; Tami-Maury I; Freyer DR; Roth M
    Cancer; 2020 Mar; 126(5):949-957. PubMed ID: 31869454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative).
    Hesko C; Mittal N; Avutu V; Thomas SM; Heath JL; Roth ME
    Curr Probl Cancer; 2023 Dec; 47(6):100898. PubMed ID: 36207194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.
    Shaw PH; Boyiadzis M; Tawbi H; Welsh A; Kemerer A; Davidson NE; Ritchey AK
    Cancer; 2012 Jul; 118(14):3614-7. PubMed ID: 22213134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children's Oncology Group's 2013 blueprint for research: adolescent and young adult oncology.
    Freyer DR; Felgenhauer J; Perentesis J;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1055-8. PubMed ID: 23424167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics.
    Siembida EJ; Loomans-Kropp HA; Tami-Maury I; Freyer DR; Sung L; Crosswell HE; Pollock BH; Roth ME
    Oncologist; 2022 May; 27(5):363-370. PubMed ID: 35522559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials 2004-2015.
    Faulk KE; Anderson-Mellies A; Cockburn M; Green AL
    PLoS One; 2020; 15(4):e0230824. PubMed ID: 32324751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.
    Avutu V; Monga V; Mittal N; Saha A; Andolina JR; Bell DE; Fair DB; Flerlage JE; Frediani JN; Heath JL; Kahn JM; Reichek JL; Super L; Terao MA; Freyer DR; Roth ME
    JCO Oncol Pract; 2022 Mar; 18(3):224-231. PubMed ID: 34905405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs.
    Dickens DS; Roth ME; Pollock BH; Langevin AM
    JCO Oncol Pract; 2020 Oct; 16(10):e1060-e1066. PubMed ID: 32396490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.